SCHEMBL30816143

SCHEMBL30816143

COC(=O)c1c(C(=O)OC)c2c(Br)cc3ccccc3n2c1C(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ PKM P14618 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALDH1A1 P00352 5/20 0.38
▸ HTT P42858 2/20 0.37
▸ SIRT6 Q8N6T7 1/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ABCC4 O15439 1/20 0.35
▸ PLIN1 O60240 1/20 0.35
▸ CACNA1F O60840 1/20 0.35
▸ GMNN O75496 1/20 0.35
▸ KCNK2 O95069 1/20 0.35
▸ ABCB11 O95342 1/20 0.35
▸ GSR P00390 1/20 0.35
▸ LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27156301 0.86 MEN1 (0.39) KMT2AMEN1RAB9APKML3MBTL1
SCHEMBL30816138 0.81 HPGD (0.41) KMT2AMEN1RAB9APKML3MBTL1
SCHEMBL30816073 0.79 MAPT (0.41) KMT2AMEN1RAB9AL3MBTL1ALDH1A1
SCHEMBL30816031 0.78 KMT2A (0.39) KMT2AMEN1L3MBTL1ALDH1A1MAPK1
SCHEMBL30816117 0.78 RAB9A (0.42) KMT2AMEN1RAB9AALDH1A1MAPK1
SCHEMBL30816139 0.78 KMT2A (0.39) KMT2AMEN1L3MBTL1ALDH1A1HTT
SCHEMBL31338813 0.76 KMT2A (0.40) KMT2AMEN1RAB9AALDH1A1HTT
SCHEMBL27156313 0.76 NOD2 (0.44) KMT2AMEN1RAB9APKML3MBTL1
SCHEMBL30816197 0.75 TRPA1 (0.41) KMT2AMEN1RAB9AALDH1A1KDM4E
SCHEMBL28229986 0.68 ALDH1A1 (0.56) KMT2AALDH1A1HTTMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents King Faisal University (SA) 2024-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents BRD4, BET1, TALDO1 KMT2A 3348/4885MEN1 3305/4885RAB9A 984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback